Study of maternal and perinatal outcome in cases of a HELLP syndrome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20231923Keywords:
HELLP syndrome, Pre-eclampsia, PregnancyAbstract
Background: HELLP is an acronym which describes the presence of haemolysis, elevated liver enzymes, low platelet count during pregnancy. It is a life-threatening manifestation of pre-eclampsia. The incidence of HELLP syndrome is 0.5-0.9% of all pregnancies and 10-20% in cases of pre-eclampsia. The rationale of this study lied in the anticipation that knowledge of incidence of the HELLP Syndrome will incite the interest of medical fraternity handling various pregnancy related complication. The results may also imply that early detection of high-risk individuals by primary medical personnel and timely referral to a tertiary care centre will be helpful in improving maternal and perinatal outcomes. Aim of this study were to study the incidence of HELLP syndrome in patients with pre-eclampsia and to study maternal and perinatal outcome in pre-eclampsia patients complicated with HELLP syndrome.
Methods: A prospective observational study of 400 admitted cases with more than 20 weeks of gestation having pre-eclampsia. Statistical analysis of the data done on IBM SPSS Statistics Version.
Results: The incidence of HELLP syndrome in pre-eclampsia was found to be 9.25%. The major maternal complications were placental abruption (35.14%), acute renal failure (16.22%), eclampsia (5.4%), papilledema (5.41%), PRES (5.41%), DIC (5.41%), maternal mortality (8.11%) in cases of HELLP syndrome while low birth weight (48.64%) respiratory distress syndrome (35.14%), meconium aspiration syndrome (18.9%), IUD (10.81%), NICU admission (37.84%), NND (10.81%) were neonatal complications.
Conclusions: HELLP syndrome in pre-eclampsia is associated with significant maternal and perinatal morbidity and mortality and early detection and prompt management is the key for a better maternal and perinatal outcome.
References
Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159-67.
Goodlin RC. Hemolysis, elevated liver enzymes and low platelets syndrome. Obstet Gynaecol. 1984;64(3):449-50.
Shennan A. Hypertensive disorders. In: Edmond DK, (ed.) Dewhurst's Text Book of Obstetrics and Gynaecology for Postgraduates. 7th ed. London: Blackwell Sciences; 2007:227-37.
Ahmed FA, Amin A, Naeem NK. HELLP syndrome, a clinical variant of pre-eclampsia. Annals. 2007;13(2):158-61.
Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Ame J Obstet Gynecol. 1993;169(4):1000-6.
Sibai BM: Imitators of severe pre-eclampsia/eclampsia. Clin Perinatol. 2004,31:835-52.
Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM: Risk factors For adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000;183:444-8.
Curtin WM, Weinstein L. A review of HELLP syndrome. J Perinatol. 1999;19(2):138-43.
Banoo S, Makhdoomi TA, Mir S, Malik J. Incidence of HELLP syndrome in sever pregnancy induced hypertension and its impact on maternal and fetal outcome. JK Practitioner. 2007;14(2):92-4.
Imir GA, Özdemir Kol I, Kaygusuz K, Çetin A, Çetin M, Güvenal T, Gönüllü M. Perinatal outcomes in HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. J Turk Ger Gynecol Assoc. 2008;9:89-93.
Kaur AP, Kaur N, Dhillon SP. HELLP syndrome and its implications on maternal and perinatal outcome. Int J Reprod Contracep Obstet Gynecol. 2018;7(3):1007-12.
Magann EF, Perry KG, Chauhan SP, Graves GR, Blake PG, Martin JN. Neonatal salvage by weeks of gestation in pregnancies complicated by HELLP syndrome. J Soc Gynecol Invest. 1994;1:206-9.
Fonseca JE, Méndez F, Cataño C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005;193(5):1591-8.
Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1999;181(4):924-928.
